Ozdarendeli, A. Et Al. 2023. Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials. VACCINE , vol.41, no.2 , 380-390.

Ozdarendeli, A., Sezer, Z., Pavel, S. T. I., Inal, A., Yetiskin, H., Kaplan, B., ... Uygut, M. A.(2023). Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials. VACCINE , vol.41, no.2, 380-390.

Ozdarendeli, AYKUT Et Al. "Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials," VACCINE , vol.41, no.2, 380-390, 2023

Ozdarendeli, AYKUT Et Al. "Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials." VACCINE , vol.41, no.2, pp.380-390, 2023

Ozdarendeli, A. Et Al. (2023) . "Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials." VACCINE , vol.41, no.2, pp.380-390.

@article{article, author={AYKUT ÖZDARENDELİ Et Al. }, title={Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials}, journal={VACCINE}, year=2023, pages={380-390} }